Autoplaque vs Withings Scan Monitor
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if you are a clinician requiring precise, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for in-depth assessment of coronary artery disease, aiding in heart attack risk stratification and guiding interventional treatment decisions within a clinical radiology or cardiology workflow.
View Autoplaque →Choose Withings Scan Monitor if…
Choose Withings Scan Monitor if you need a convenient, device-based solution for continuous personal health monitoring or remote patient monitoring, particularly for early detection of atrial fibrillation and tracking general vital health metrics. This is well-suited for individuals or healthcare providers seeking accessible, long-term data collection in a home or outpatient setting.
View Withings Scan Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Withings Scan Monitor |
|---|---|---|
| Pricing | Unknown | Device purchase with optional subscription for enhanced features and clinical services. |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Withings Scan MonitorWithings Scan Monitor (Tool B) offers superior usability for a broader audience due to its device-based deployment (smart scale, smartwatch) with seamless cloud synchronization and a mobile application. This design provides a lower barrier to entry and more intuitive interaction for both personal use and remote patient monitoring. Autoplaque (Tool A), while likely highly usable for its specialized clinical users, is a workstation-based post-processing application, which implies a more specialized and less broadly accessible user experience.
Clinical Value
AutoplaqueAutoplaque (Tool A) provides deep, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance, which is a high-stakes diagnostic capability. Withings Scan Monitor (Tool B) offers valuable monitoring for AFib detection and other vital signs, but Autoplaque's specialized diagnostic output for a critical condition represents a more profound clinical impact in terms of guiding complex medical decisions.
Pricing & Value
Withings Scan MonitorWithings Scan Monitor (Tool B) provides transparent pricing with a clear device purchase cost and an optional subscription for enhanced features, allowing users to easily assess its value proposition. Autoplaque (Tool A) has not disclosed its pricing, making it impossible to evaluate its cost-effectiveness or overall value in comparison.
Enterprise Readiness
Withings Scan MonitorWithings Scan Monitor (Tool B) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for secure and compliant deployment within healthcare enterprises. Its device-based, cloud-synchronized architecture also supports scalable remote patient monitoring programs. Autoplaque (Tool A) is workstation-based and does not specify HIPAA compliance or BAA, indicating a potentially lower level of readiness for large-scale enterprise integration and data governance.
Innovation
AutoplaqueAutoplaque (Tool A) demonstrates a highly specialized and innovative application of AI for quantitative analysis of complex coronary plaque morphology and stenosis from CT angiography images, moving beyond traditional qualitative assessments. This provides a novel diagnostic capability for personalized risk prediction. While Withings Scan Monitor (Tool B) innovatively integrates multiple health metrics and AI into consumer wearables, Autoplaque's deep learning application for detailed plaque characterization in diagnostic imaging represents a more significant advancement in a specialized clinical domain.
Support & Docs
Withings Scan MonitorWithings Scan Monitor (Tool B), as a commercial product, offers comprehensive and publicly accessible support resources, including user manuals, FAQs, and troubleshooting guides on its website. Autoplaque (Tool A), developed by a medical center, does not have readily available public support documentation, suggesting that its support might be more tailored or internal for its specific clinical users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Withings Scan Monitor |
|---|---|---|
| Name | Autoplaque | Withings Scan Monitor |
| Company | Cedars-Sinai Medical Center: AIM | Withings |
| Primary Use Case | AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring. |
| Core Functionality | AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses. | 6-lead ECG for Atrial Fibrillation (AFib) detection, heart rate measurement, vascular age assessment, nerve health score. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Withings Scan Monitor.